Khavinson Bioregulator · Chondrocyte-Targeted
Cartalax is a synthetic peptide complex derived from cartilage tissue extracts, part of the bioregulator peptide family. It consists of short amino acid chains designed to influence chondrocyte gene expression and the production of extracellular matrix components — the glue that holds cartilage together.
What It's Being Studied To Do
- Support chondrocyte proliferation and activity
- Promote cartilage matrix synthesis (collagen, proteoglycans, glycosaminoglycans)
- Improve joint structural integrity and lubrication
- Modulate inflammatory signals within joint tissue
- Enhance cartilage repair pathways in degenerative models
- Slow age-related breakdown
Why This Matters
Cartilage wear contributes to joint pain, osteoarthritis, and limited movement — issues that reduce quality of life as we age. Cartalax research explores how targeted signaling might help restore cartilage health from within, supporting the body's design for durable, flexible joints that enable active, pain-free living.
Preclinical studies (primarily Russian) suggest improved cartilage thickness and elasticity, reduced degenerative markers, better joint mobility scores, enhanced matrix production, and support for structural resilience — positioned as a preventive bioregulator for joint longevity.